Medicare Enrolled
Dr. Dalton Dove, M.D.
Pulmonary Disease · Goldsboro, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dove from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dove?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dove
Dr. Dalton Dove is a pulmonary disease specialist in Goldsboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dove performed 1,413 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dove received a total of $5,568 from 65 pharmaceutical and/or device companies across 312 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dove is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in NC
$5,568 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,413
Medicare services
Top 22% in NC for pulmonary disease
Not available
Unique patients (not deduplicated)
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
391 | $164 | $612 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
168 | $6 | $31 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
157 | $25 | $134 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
150 | $27 | $116 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
140 | $21 | $105 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
119 | $124 | $330 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
112 | $91 | $255 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
44 | $65 | $488 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
42 | $84 | $336 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $87 | $250 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
24 | $7 | $136 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
24 | $74 | $364 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
15 | $109 | $456 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.1% high complexity
0.0% medium
96.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,568
Total received (2018-2024)
Avg $795/year across 7 years
Top 32% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
312
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$561
2023
$554
2022
$663
2021
$1,031
2020
$895
2019
$1,042
2018
$822
Payments by company (2024)
MDD US Operations, LLC
$74
GENZYME CORPORATION
$71
ABBVIE INC.
$64
Merck Sharp & Dohme LLC
$63
GlaxoSmithKline, LLC.
$51
Biogen, Inc.
$49
Neurelis, Inc.
$43
Alexion Pharmaceuticals, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$27
Baxter Healthcare
$26
Insmed, Inc.
$22
Abbott Laboratories
$21
Inspire Medical Systems, Inc.
$18
Top 3 companies account for 37.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$521
Genentech USA, Inc.
$423
Supernus Pharmaceuticals, Inc.
$404
GlaxoSmithKline, LLC.
$351
Teva Pharmaceuticals USA, Inc.
$314
UCB, Inc.
$292
Boehringer Ingelheim Pharmaceuticals, Inc.
$229
Philips Electronics North America Corporation
$163
Alexion Pharmaceuticals, Inc.
$128
Amgen Inc.
$122
AbbVie Inc.
$117
SK Life Science, Inc.
$114
MDD US Operations, LLC
$110
Biohaven Pharmaceutical Holding Company Ltd.
$107
Merck Sharp & Dohme LLC
$104
AstraZeneca Pharmaceuticals LP
$103
Mallinckrodt Hospital Products Inc.
$99
Mylan Specialty L.P.
$89
Neurocrine Biosciences, Inc.
$84
EISAI INC.
$84
Insmed, Inc.
$79
ABBVIE INC.
$79
Merck Sharp & Dohme Corporation
$74
GENZYME CORPORATION
$71
Regeneron Healthcare Solutions, Inc.
$71
Biogen, Inc.
$70
Lilly USA, LLC
$69
Eisai Inc.
$64
Neurelis, Inc.
$63
Amneal Pharmaceuticals LLC
$62
Novo Nordisk Inc
$60
PFIZER INC.
$59
Advanced Respiratory, Inc
$52
Amarin Pharma Inc.
$48
Allergan Inc.
$47
Baxter Healthcare
$46
Biohaven Pharmaceuticals, Inc.
$43
Abbott Laboratories
$43
Lundbeck LLC
$40
Avion Pharmaceuticals
$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
Adamas Pharmaceuticals, Inc.
$28
Avanir Pharmaceuticals, Inc.
$26
BANNER LIFE SCIENCES, LLC
$24
Actelion Pharmaceuticals US, Inc.
$23
Exact Sciences Corporation
$21
Sunovion Pharmaceuticals Inc.
$20
Vertical Pharmaceuticals, LLC
$20
Jazz Pharmaceuticals Inc.
$19
Dexcom, Inc.
$19
Inspire Medical Systems, Inc.
$18
Circassia Pharmaceuticals Inc
$17
VIVUS, Inc.
$16
Acorda Therapeutics, Inc
$15
ARBOR PHARMACEUTICALS, INC.
$14
Mallinckrodt Enterprises LLC
$14
Astellas Pharma US Inc
$13
EMD Serono, Inc.
$13
Arbor Pharmaceuticals, Inc.
$13
Janssen Pharmaceuticals, Inc
$13
Synergy Pharmaceuticals Inc
$12
BioDelivery Sciences International, Inc.
$12
LivaNova USA, Inc.
$11
Takeda Pharmaceuticals U.S.A., Inc.
$10
Inogen, Inc.
$9
Top 3 companies account for 24.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIMOVIG · AJOVY · ANORO · ANORO ELLIPTA · AUSTEDO · AVONEX · AVYCAZ · Aimovig · Arikayce · BAFIERTAM · BELBUCA · Briviact · COMIRNATY · Cologuard Collection Kit · DIFICID · DUPIXENT · Dayvigo · Dexcom G6 Transmitter · Dhivy · ELIQUIS · EMGALITY · Esbriet · FASENRA · FreeStyle Libre 2 · Fycompa · GOCOVRI · Gocovri · Hillrom - Life 2000 Ventilation System · Horizant · INBRIJA · INGREZZA · INSPIRE · InogenOne · JARDIANCE · KESIMPTA · KEYTRUDA · LINZESS · LOKELMA · LONHALA MAGNAIR · MYRBETRIQ · NORTHERA · NUCALA · NUEDEXTA · NURTEC ODT · OFEV · ONGENTYS · OPSUMIT · OXTELLAR XR · Ongentys · Ozempic · PROCLAIM · QSYMIA · QULIPTA · RELEXXII · RYBELSUS · RYTARY · Rebif · Respiratoriy Care Undiv · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Soliris · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · TUDORZA PRESSAIR · TYSABRI · The Vest System Model 105 Home Care · Tresiba · Trintellix · Trulance · UBRELVY · ULTOMIRIS · Utibron · VALTOCO · VNS Therapy · VYEPTI · Vascepa · Vimpat · XIFAXAN · XOLAIR · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
7
County median income
$58,082
Nearest hospital to ZIP centroid (approximate)
UNC HEALTH CARE WAYNE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dove is a mixed practice specialist, with above-average Medicare volume (top 22% in NC), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dove experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Dove performed 391 critical care, first 30-74 min services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dove receive payments from pharmaceutical companies?
Yes. Dr. Dove received a total of $5,568 from 65 companies across 312 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dove's costs compare to other pulmonary diseases in Goldsboro?
Dr. Dove's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dove) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Goldsboro
Browse pulmonary diseases in Goldsboro ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology